CMBA
PFE icon

C.M. Bidwell & Associates’s Pfizer PFE Stock Holding History

C.M. Bidwell & Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Buy
13,108
+1,687
+15% +$44.1K 0.13% 103
2026
Q1 		$321K Sell
11,421
-67
-0.6% -$1.78K 0.15% 84
2025
Q4 		$286K Sell
11,488
-387
-3% -$9.76K 0.14% 102
2025
Q3 		$303K Sell
11,875
-892
-7% -$22K 0.15% 89
2025
Q2 		$309K Sell
12,767
-630
-5% -$14.7K 0.16% 89
2025
Q1 		$339K Sell
13,397
-223
-2% -$5.83K 0.2% 84
2024
Q4 		$361K Buy
13,620
+2,900
+27% +$78.7K 0.22% 76
2024
Q3 		$310K Buy
+10,720
New +$313K 0.19% 86
2022
Q3 		– Sell
-6,022
Closed -$316K – 524
2022
Q2 		$316K Sell
6,022
-2,415
-29% -$123K 0.25% 64
2022
Q1 		$437K Sell
8,437
-198
-2% -$10.3K 0.29% 56
2021
Q4 		$510K Buy
+8,635
New +$428K 0.31% 50
2019
Q3 		– Sell
-11,757
Closed -$483K – 470
2019
Q2 		$483K Buy
11,757
+10,940
+1,339% +$434K 0.48% 54
2019
Q1 		$33K Hold
817
– – 0.03% 279
2018
Q4 		$34K Buy
+817
New +$33.9K 0.04% 269
2017
Q1 		– Sell
-118
Closed -$4K – 280
2016
Q4 		$4K Sell
118
-130,615
-100% -$3.99M ﹤0.01% 225
2016
Q3 		$4.2M Sell
130,733
-395
-0.3% -$13.2K 1% 31
2016
Q2 		$4.38M Sell
131,128
-106
-0.1% -$3.38K 1.09% 21
2016
Q1 		$3.69M Buy
+131,234
New +$3.75M 0.92% 55
2014
Q2 		– Sell
-1,697
Closed -$52K – 280
2014
Q1 		$52K Sell
1,697
-79,946
-98% -$2.38M 0.01% 202
2013
Q4 		$2.37M Sell
81,643
-284
-0.3% -$8.27K 0.59% 83
2013
Q3 		$2.23M Buy
81,927
+295
+0.4% +$8.03K 0.61% 84
2013
Q2 		$2.17M Buy
+81,632
New +$2.26M 0.64% 80

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

C.M. Bidwell & Associates's PFE Position: Q2 2026 in Review

C.M. Bidwell & Associates increased its Pfizer (PFE) stake by 15% in Q2 2026, buying an estimated $44.1K and bringing the position to 13,108 shares worth $316K. The position accounts for 0.13% of the portfolio, ranked #103.

C.M. Bidwell & Associates first reported a position in PFE in Q2 2013 and has held it in 22 quarters since. The position peaked at $4.38M in Q2 2016. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • C.M. Bidwell & Associates held 13,108 shares of Pfizer worth $316K as of Q2 2026.
  • C.M. Bidwell & Associates bought 1,687 Pfizer shares in Q2 2026, an estimated $44.1K.
  • Pfizer made up 0.13% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #103 holding.
  • C.M. Bidwell & Associates first reported a position in Pfizer in Q2 2013 and has held it in 22 quarters since.
  • C.M. Bidwell & Associates's Pfizer position peaked at $4.38M in Q2 2016.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.